Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Tnip2em1/Cya
Common Name:
Tnip2-KO
Product ID:
S-KO-06418
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Tnip2-KO
Strain ID
KOCMP-231130-Tnip2-B6J-VA
Gene Name
Tnip2
Product ID
S-KO-06418
Gene Alias
1810020H16Rik; ABIN-2
Background
C57BL/6JCya
NCBI ID
231130
Modification
Conventional knockout
Chromosome
5
Phenotype
MGI:2386643
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Tnip2em1/Cya mice (Catalog S-KO-06418) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000087737
NCBI RefSeq
NM_139064
Target Region
Exon 3~5
Size of Effective Region
~1.8 kb
Detailed Document
Click here to download >>
Overview of Gene Research
TNIP2, also known as ABIN2, is a protein that functions as a negative regulator of NF-κB signaling. It binds to A20 to suppress inflammatory cytokines-induced NF-κB activation, thus inhibiting inflammatory response and apoptosis. It is also involved in RNA metabolism. The NF-κB signaling pathway is pivotal in controlling cellular responses to environmental stresses, and TNIP2's role in this pathway is crucial for maintaining normal cellular function [1,5,6].

In various disease conditions, TNIP2 has been shown to play significant roles. In Alzheimer's disease (AD) cell and mouse models, TNIP2 protein level declined significantly. Overexpression of TNIP2 decreased β-secretase (BACE1) and C99 protein levels, as well as Aβ peptides, by promoting BACE1 mRNA degradation through binding to its 3' untranslated region, effectively inhibiting amyloidogenic processing [1]. In major depressive disorder (MDD), TNIP2 mRNA expression was higher in monocytes from patients, positively correlated with GRβ expression and depression severity. GRβ overexpression promoted TNIP2 and TNF-α mRNA levels, and TNIP2 was required for GRβ-mediated TNF-α increase, suggesting the GRβ/TNIP2/TNF-α axis may induce inflammation in MDD [2]. In rheumatoid arthritis (RA), multi-ancestry genome-wide association analyses identified TNIP2 as a candidate gene, suggesting its role in the disease's etiology [3]. In pulmonary arterial hypertension (PAH), a novel missense variant in TNIP2 was discovered in affected individuals. TNIP2 knockdown increased NF-κB activity and cell proliferation in healthy lung pericytes, indicating its role in pulmonary vascular remodeling [4]. In spinal cord injury (SCI) rat models, TNIP2 expression increased, and its overexpression inhibited M1 polarization and pro-inflammatory cytokine production in microglia, protecting against inflammatory responses [5]. In bronchopulmonary dysplasia (BPD), TNIP2, as a direct target of miR34a, negatively regulated the activation of NLRP3 inflammasome and production of IL-1β. Overexpressing TNIP2 ameliorated hyperoxia-induced IL-1β production and cell apoptosis, suggesting it may be a potential clinical marker for BPD [7]. In multiple organ dysfunction syndrome (MODS) following severe trauma, TNIP2 was decreased in patients and MODS rats. TNIP2-plasmid administration inhibited the increase in inflammatory and oxidative stress-related markers and NF-κB activation in MODS rats, indicating its protective role [8]. In osteoarthritis (OA), NAV2-AS5 relieved chondrocyte inflammation by targeting miR-8082/TNIP2, with TNIP2 downregulated in OA patients [9].

In conclusion, TNIP2 is a key regulator in the NF-κB signaling pathway and RNA metabolism. Through studies using various disease models such as those for AD, MDD, RA, PAH, SCI, BPD, MODS, and OA, TNIP2 has been shown to play important roles in inflammation, apoptosis, and disease-related processes. These model-based studies help in understanding the biological functions of TNIP2 and provide potential therapeutic targets for these diseases.

References:

1. Chen, Long, Wang, Lu, Zhou, Gui-Feng, Yang, Jie, Chen, Guo-Jun. 2023. TNIP2 inhibits amyloidogenesis by regulating the 3'UTR of BACE1: An in vitro study. In Neuroscience letters, 808, 137265. doi:10.1016/j.neulet.2023.137265. https://pubmed.ncbi.nlm.nih.gov/37085111/

2. Chiang, Ting-I, Hung, Yi-Yung, Wu, Ming-Kung, Huang, Ya-Ling, Kang, Hong-Yo. 2021. TNIP2 mediates GRβ-promoted inflammation and is associated with severity of major depressive disorder. In Brain, behavior, and immunity, 95, 454-461. doi:10.1016/j.bbi.2021.04.021. https://pubmed.ncbi.nlm.nih.gov/33932528/

3. Ishigaki, Kazuyoshi, Sakaue, Saori, Terao, Chikashi, Okada, Yukinori, Raychaudhuri, Soumya. 2022. Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. In Nature genetics, 54, 1640-1651. doi:10.1038/s41588-022-01213-w. https://pubmed.ncbi.nlm.nih.gov/36333501/

4. Pienkos, Shaun, Gallego, Natalia, Condon, David F, Tenorio-Castaño, Jair, de Jesús Pérez, Vinicio A. 2021. Novel TNIP2 and TRAF2 Variants Are Implicated in the Pathogenesis of Pulmonary Arterial Hypertension. In Frontiers in medicine, 8, 625763. doi:10.3389/fmed.2021.625763. https://pubmed.ncbi.nlm.nih.gov/33996849/

5. Fu, Jiawei, Wu, Chunshuai, Xu, Guanhua, Ji, Chunyan, Cui, Zhiming. 2023. Protective effect of TNIP2 on the inflammatory response of microglia after spinal cord injury in rats. In Neuropeptides, 101, 102351. doi:10.1016/j.npep.2023.102351. https://pubmed.ncbi.nlm.nih.gov/37329819/

6. Banks, Charles A S, Boanca, Gina, Lee, Zachary T, Florens, Laurence, Washburn, Michael P. 2016. TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. In Molecular & cellular proteomics : MCP, 15, 3435-3449. doi:. https://pubmed.ncbi.nlm.nih.gov/27609421/

7. Tao, Xuwei, Mo, Luxia, Zeng, Lingkong. 2022. Hyperoxia Induced Bronchopulmonary Dysplasia-Like Inflammation via miR34a-TNIP2-IL-1β Pathway. In Frontiers in pediatrics, 10, 805860. doi:10.3389/fped.2022.805860. https://pubmed.ncbi.nlm.nih.gov/35433535/

8. Gong, Hui, Sheng, Xiaomin, Xue, Jianhua, Zhu, Dongbo. 2019. Expression and role of TNIP2 in multiple organ dysfunction syndrome following severe trauma. In Molecular medicine reports, 19, 2906-2912. doi:10.3892/mmr.2019.9893. https://pubmed.ncbi.nlm.nih.gov/30720079/

9. Wang, Pu, Wang, Yuhao, Ma, Baoan. 2022. Long noncoding RNA NAV2-AS5 relieves chondrocyte inflammation by targeting miR-8082/TNIP2 in osteoarthritis. In Cell cycle (Georgetown, Tex.), 22, 796-807. doi:10.1080/15384101.2022.2154554. https://pubmed.ncbi.nlm.nih.gov/36503346/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest